Matches in SemOpenAlex for { <https://semopenalex.org/work/W1486853281> ?p ?o ?g. }
- W1486853281 abstract "Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic synovial inflammation. Many cells of the immune system are involved in this chronic inflammatory process. The primary target organs are the joints although as the disease progresses systemic manifestations often also appear. As a consequence of the inflammatory process, RA patients generally develop a progressive loss of cartilage and bone in joints, resulting in painful joints and impaired functional status. Understanding the immune-pathogenic development of RA is a crucial step toward improving its management. In this thesis we focused on two major points: gaining more insight into the immune-pathogenic mechanisms underlying RA and investigating the possible anti-inflammatory role of HSP70. In order to study arthritis, we made use of the proteoglycan-induced arthritis (PGIA) model in BALB/c mice, which is a T cell-dependent, autoantibody-mediated progressive relapsing autoimmune model resembling many characteristics of RA. Originally PGIA was induced by four PG immunizations of which the first and fourth injection were in complete Freund's adjuvant (CFA) and the second and third PG injection in incomplete Freund's adjuvant (IFA). In chapter 2 (published in Arthritis & Rheumatism 2004;50(5):1665-76) we described that by replacing the Freund's adjuvants by dimethyldioctadecylammonium bromide (DDA), arthritis can be induced by only two PG immunizations. Although the clinical and immunological features of the “classic” form of PGIA are preserved, the onset of the disease is faster and the severity is increased. An additional advantage is that hereby all undesired side effects of the Freund's adjuvants, such as the role of interfering immune responses induced by microbial HSPs present in CFA, are eliminated. DDA exerted a strong stimulatory effect via the activation of innate immunity and forced the immune response toward Th1 dominance (chapter 2). In the PGIA model using DDA as adjuvant, we explored the anti-inflammatory capacity of immune responses to HSP70 in arthritis and searched for the mechanisms involved (chapter 3, manuscript submitted). HSP70 pretreatment dramatically suppressed the development of inflammation and subsequent tissue damage in PGIA. Moreover, HSP70 pretreatment resulted in a regulatory immune response not only to HSP70 but also to PG. To better understand the role of T cells in arthritis we generated a T cell receptor transgenic (TCR-Tg) mouse (chapter 4, accepted Journal of Autoimmunity and chapter 5, manuscript submitted). The T cells of this mouse are specific for an epitope (designated 5/4E8) in the G1 domain of human cartilage PG (amino acids 70-84). These TCR-5/4E8-Tg mice are a unique source of naive antigen-specific T cells that are capable of inducing progressive chronic arthritis, both spontaneously ( As in PGIA, T cell responses against cartilage PG do also occur in RA, at least in a subset of patients. In chapter 6 (manuscript in preparation) we tested for responses to several PG epitopes in longstanding RA patients compared to osteoarthritis (OA) patients and healthy controls. In particular, two epitopes (amino acids 16-39 and 263-282; both located in the G1 domain of human PG) appeared to be frequently recognized RA and OA patients as shown by proliferation and preferential Th1 cytokine production. This indicates that PG-specific responses might be involved in RA immune pathogenesis either primarily or, more likely, as a consequence of cartilage destruction. Taken together, PG-specific immune responses were studied in PGIA as well as in RA and showed that the PGIA model provides a unique opportunity to study possible autoimmune mechanisms. Pretreatment with HSP70 showed the potential to modulate (suppress) the arthritogenic effect of PG via IL-10 mediated response and thus to treat arthritis. RA is a complex autoimmune disease controlled by various cells of innate and adaptive immunities, environmental factors and genetic components. A successful treatment of RA will depend on the early diagnosis and a better understanding of pathological processes. The PGIA model enabled the investigation of several in vivo mechanisms in a complex system of inflammation and autoimmunity. The analysis of PGs and HSPs, both present at the site of inflammation, provided insight into the pathogenesis of autoimmunity and arthritis and suggests that both proteins may be targets of immunomodulation by different mechanisms." @default.
- W1486853281 created "2016-06-24" @default.
- W1486853281 creator A5080635223 @default.
- W1486853281 date "2006-02-15" @default.
- W1486853281 modified "2023-09-23" @default.
- W1486853281 title "Regulation of proteoglycan-specific immune responses in arthritis" @default.
- W1486853281 cites W13080489 @default.
- W1486853281 cites W1490165777 @default.
- W1486853281 cites W1495122617 @default.
- W1486853281 cites W1498185604 @default.
- W1486853281 cites W1504079946 @default.
- W1486853281 cites W1504400337 @default.
- W1486853281 cites W1525177589 @default.
- W1486853281 cites W1526621387 @default.
- W1486853281 cites W1530782041 @default.
- W1486853281 cites W1542080278 @default.
- W1486853281 cites W1561046927 @default.
- W1486853281 cites W1585863855 @default.
- W1486853281 cites W1586192659 @default.
- W1486853281 cites W1605934957 @default.
- W1486853281 cites W1608362877 @default.
- W1486853281 cites W1611284225 @default.
- W1486853281 cites W1657484783 @default.
- W1486853281 cites W1672905910 @default.
- W1486853281 cites W1753553692 @default.
- W1486853281 cites W1769726125 @default.
- W1486853281 cites W1791999994 @default.
- W1486853281 cites W1792973268 @default.
- W1486853281 cites W1818320070 @default.
- W1486853281 cites W1820973630 @default.
- W1486853281 cites W1847502039 @default.
- W1486853281 cites W1856044063 @default.
- W1486853281 cites W189264004 @default.
- W1486853281 cites W1905100933 @default.
- W1486853281 cites W1910056502 @default.
- W1486853281 cites W1920839104 @default.
- W1486853281 cites W1934581960 @default.
- W1486853281 cites W1951812021 @default.
- W1486853281 cites W1952548524 @default.
- W1486853281 cites W1960767717 @default.
- W1486853281 cites W1963515292 @default.
- W1486853281 cites W1964372860 @default.
- W1486853281 cites W1964479886 @default.
- W1486853281 cites W1965068387 @default.
- W1486853281 cites W1965555677 @default.
- W1486853281 cites W1966609293 @default.
- W1486853281 cites W1967767979 @default.
- W1486853281 cites W1968496833 @default.
- W1486853281 cites W1969088892 @default.
- W1486853281 cites W1969212374 @default.
- W1486853281 cites W1969250152 @default.
- W1486853281 cites W1970404248 @default.
- W1486853281 cites W1971526956 @default.
- W1486853281 cites W1971890827 @default.
- W1486853281 cites W1974943986 @default.
- W1486853281 cites W1975519519 @default.
- W1486853281 cites W1976912963 @default.
- W1486853281 cites W1978103379 @default.
- W1486853281 cites W1978117435 @default.
- W1486853281 cites W1978351757 @default.
- W1486853281 cites W1980752022 @default.
- W1486853281 cites W1980990177 @default.
- W1486853281 cites W1981047016 @default.
- W1486853281 cites W1982425773 @default.
- W1486853281 cites W1983521458 @default.
- W1486853281 cites W1987224476 @default.
- W1486853281 cites W1987961062 @default.
- W1486853281 cites W1988280501 @default.
- W1486853281 cites W1989069694 @default.
- W1486853281 cites W1989261293 @default.
- W1486853281 cites W1989515097 @default.
- W1486853281 cites W1990227965 @default.
- W1486853281 cites W1990349812 @default.
- W1486853281 cites W1990701502 @default.
- W1486853281 cites W1993484569 @default.
- W1486853281 cites W1993986909 @default.
- W1486853281 cites W1994048581 @default.
- W1486853281 cites W1996087599 @default.
- W1486853281 cites W1996644394 @default.
- W1486853281 cites W1999301958 @default.
- W1486853281 cites W2001075515 @default.
- W1486853281 cites W2003164422 @default.
- W1486853281 cites W2003666655 @default.
- W1486853281 cites W2006474879 @default.
- W1486853281 cites W2006704636 @default.
- W1486853281 cites W2007606955 @default.
- W1486853281 cites W2007983412 @default.
- W1486853281 cites W2008176536 @default.
- W1486853281 cites W2008451878 @default.
- W1486853281 cites W2010771259 @default.
- W1486853281 cites W2011361075 @default.
- W1486853281 cites W2012064275 @default.
- W1486853281 cites W2013116991 @default.
- W1486853281 cites W2013743800 @default.
- W1486853281 cites W2014081699 @default.
- W1486853281 cites W2016671523 @default.
- W1486853281 cites W2019675509 @default.
- W1486853281 cites W2020317622 @default.
- W1486853281 cites W2021215186 @default.
- W1486853281 cites W2022636992 @default.